SlideShare a Scribd company logo
1 of 13
FARMAKOKINETIKA DOSIS GANDA
( III )
INFUSI - INTRAVENA
INTRAVENA INTRAVENA BOLUS
INTRAVENA LAMBAT – LAJU TETAP
INFUSI INTRAVENA
- PENGENDALIAN TEPAT Cp ~ kebutuhan pasien
- HILANGKAN FLUKTUASI YANG BESAR
CMAKS -- CMIN
Ex. Oksitosin, heparin, aminofilin, cairan elektrolit, nutrient
Fig. 5-1. Plasma level-time curve for constant IV infusion
Pada keadaan tunak
laju masukan obat = laju obat keluar
(laju infusi) (laju eliminasi)
dc/dt = 0
OBAT – MODEL KOMPARTEMEN SATU
B
B
kD
R
dt
dD


 
kt
D
e
k
V
R
Cp 

 1
  Cl
R
k
V
R
e
k
V
R
Cp
D
D



 

1
Perubahan jumlah obat dalam tubuh pada berbagai waktu
Integrasi persamaan di atas dan substitusi DB = CpVD
Infusi berlanjut t = ~  e-kt mendekati nol
DB = jumlah obat dalam tubuh
R = laju infusi – order nol
k = tetapan laju eliminasi – order satu
CSS
?? LAJU INFUSI  CSS
tSS
Fig. 5-3. Plasma level – time curve for IV infusions given at
rates of R and 2R, respectively
CONTOH : Hal. 111 no.1
Suatu antibiotika Vd = 10 L, k = 0,2 jam-1, Css = 10 ug/mL
Berapakah laju infusi untuk mempertahankan konsentrasi tersebut ??
R = Css Vd k
R = (10 ug/m) (10.000 mL) ( 0,2 jam-1)
R = 20 mg/jam
Bila pasien dalam kondisi uremia, tetapan laju eliminasi menurun menjadi 0,1 jam-1
Laju infusi yang baru :
R = (10 ug/m) (10.000 mL) ( 0,1 jam-1)
R = 10 mg/jam
INFUSI INTRAVENA  ClT, k, t1/2
Css
R
Cl
Css
R
k
Vd
k
Vd
R
C
T
SS



 
 





 








 










Css
Cp
Css
t
k
kt
Css
Cp
Css
e
Css
Css
Cp
e
Css
Cp
maka
k
V
R
Css
karena
e
k
V
R
Cp
kt
kt
D
kt
D
log
3
,
2
3
,
2
log
1
1
Lihat contoh
hal 112 dan 113
Fig 5-4. IV Infusion with loading dose DL
DL is given by IV bolus injection at the start of infusion
Cp decline exponentially after DL whereas they increase exponentially
During the infusion. The resulting Cp versus time curve is a straight line
due to the summation of the two curve
DOSIS MUATAN PLUS INFUSI IV:
MODEL KOMPARTEMEN SATU
Apa tujuan DL???
DOSIS MUATAN PLUS INFUSI IV:
MODEL KOMPARTEMEN SATU
1 0
2
( )
(1 )
kt kt
L
d
L
kt
d
DOSIS MUATAN D IV BOLUS
INFUSI DENGAN LAJU R
R
C e
C C e e
V
V
D
k
 

 
 

DL = Css Vd
Css . Vd= R/k
DL = R/k
!! Css  C terapetik Css
1 2
(1 )
( )
( )
L
kt
d
kt
d d
kt
L
kt
L
d
kt
L
d
kt
L
d
L
d d
L
d d
D
e
V
D
e
D dan AWAL INFUSI WAKTU SAMA
Cp C C
R
Cp e
V k
R R
Cp e
V k V k
D D
Cp e
V
D
e
V V
D R
Cp
V V k
V






 
  
  
  
   Css
Fig. 5-5. IV Infusion with loading doses a, b, and c.
Curve d represents an IV infusion without a loading dose
a  DL > R/k
b  DL = R/k
c  DL < R/k
!! Cara lain perhit DL
DL = Css . Vd
Cp – SETELAH INFUSI DIHENTIKAN
t – waktu infusi + post infusi
b – waktu infusi
  )
(
1
.
b
t
k
kb
e
e
k
Vd
R
Cp 




CARA LAIN LIHAT HAL 191
LIHAT LATIHAN SOAL HAL. 118 dst.
INFUSI IV INTERMITTEN HAL 197
PRINSIP SAMA
REGIMENTASI DOSIS ORAL GANDA
N – jumlah dosis
- jarak pendosisan
F – fraksi dosis terabsorpsi
t – waktu setelah do ke n




























 





kt
k
nk
t
k
k
nk
e
e
e
e
e
e
ka
k
Vd
D
ka
F
Cp a
a
a




1
1
1
1
)
(
.
. 0
 



T
av
av
D
av
Cl
FD
C
AUC
C
k
V
FD
C
0
~
~
0
~
0
~



PADA KEADAAN TUNAK
k
k
k
k
t
e
e
ka
k
Vd
kaFD
C
e
e
Vd
FD
C
e
e
e
e
ka
k
Vd
D
ka
F
C
a
a
maks
k
k
kt
k
maks
t
k
k
kt
k
p
p
a
a
log
3
,
2
1
1
)
(
1
1
1
1
1
1
)
(
.
.
0
~
min
0
~
0
~
























































More Related Content

What's hot

Drp interaksi obat [autosaved]
Drp interaksi obat [autosaved]Drp interaksi obat [autosaved]
Drp interaksi obat [autosaved]
husnul khotimah
 
Farmakokinetika pengaturan dosis
Farmakokinetika   pengaturan dosisFarmakokinetika   pengaturan dosis
Farmakokinetika pengaturan dosis
Dwi Ramdhini
 

What's hot (20)

Basic pharmacokinetics
Basic pharmacokineticsBasic pharmacokinetics
Basic pharmacokinetics
 
Uji Disolusi
Uji DisolusiUji Disolusi
Uji Disolusi
 
Biofarmasetika i
Biofarmasetika iBiofarmasetika i
Biofarmasetika i
 
Studi Kasus Farmakoterapi Infeksi Pneumonia
Studi Kasus Farmakoterapi Infeksi PneumoniaStudi Kasus Farmakoterapi Infeksi Pneumonia
Studi Kasus Farmakoterapi Infeksi Pneumonia
 
Tetes Mata
Tetes MataTetes Mata
Tetes Mata
 
Ekskresi dan klirens ginjal
Ekskresi dan klirens ginjalEkskresi dan klirens ginjal
Ekskresi dan klirens ginjal
 
Analisis resep
Analisis resepAnalisis resep
Analisis resep
 
Farmakokinetik Klinik Digoxin
Farmakokinetik Klinik DigoxinFarmakokinetik Klinik Digoxin
Farmakokinetik Klinik Digoxin
 
Pedoman farmakoekonomi
Pedoman farmakoekonomiPedoman farmakoekonomi
Pedoman farmakoekonomi
 
PENGANTAR FARMAKOKINETIK
PENGANTAR FARMAKOKINETIKPENGANTAR FARMAKOKINETIK
PENGANTAR FARMAKOKINETIK
 
Pengenalan resep
Pengenalan resepPengenalan resep
Pengenalan resep
 
Drp interaksi obat [autosaved]
Drp interaksi obat [autosaved]Drp interaksi obat [autosaved]
Drp interaksi obat [autosaved]
 
DRUGS DELIVERY SYSTEM
DRUGS DELIVERY SYSTEMDRUGS DELIVERY SYSTEM
DRUGS DELIVERY SYSTEM
 
Rangkuman Toksikologi dan Antidotum
Rangkuman Toksikologi dan AntidotumRangkuman Toksikologi dan Antidotum
Rangkuman Toksikologi dan Antidotum
 
Farmakokinetika pengaturan dosis
Farmakokinetika   pengaturan dosisFarmakokinetika   pengaturan dosis
Farmakokinetika pengaturan dosis
 
Ilmu resep
Ilmu resepIlmu resep
Ilmu resep
 
Studi Kasus Drug Related Problems
Studi Kasus Drug Related ProblemsStudi Kasus Drug Related Problems
Studi Kasus Drug Related Problems
 
Sediaan liquid 1
Sediaan liquid 1Sediaan liquid 1
Sediaan liquid 1
 
Faktor-Faktor yang Berpengaruh Terhadap Proses Pelepasan, Pelarutan dan Abso...
Faktor-Faktor yang Berpengaruh Terhadap  Proses Pelepasan, Pelarutan dan Abso...Faktor-Faktor yang Berpengaruh Terhadap  Proses Pelepasan, Pelarutan dan Abso...
Faktor-Faktor yang Berpengaruh Terhadap Proses Pelepasan, Pelarutan dan Abso...
 
Pengembangan obat herbal
Pengembangan obat herbalPengembangan obat herbal
Pengembangan obat herbal
 

Recently uploaded

Lipids: types, structure and important functions.
Lipids: types, structure and important functions.Lipids: types, structure and important functions.
Lipids: types, structure and important functions.
Cherry
 
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
US Environmental Protection Agency (EPA), Center for Computational Toxicology and Exposure
 
Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.
Cherry
 
CYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptxCYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptx
Cherry
 
POGONATUM : morphology, anatomy, reproduction etc.
POGONATUM : morphology, anatomy, reproduction etc.POGONATUM : morphology, anatomy, reproduction etc.
POGONATUM : morphology, anatomy, reproduction etc.
Cherry
 
GENETICALLY MODIFIED ORGANISM'S PRESENTATION.ppt
GENETICALLY MODIFIED ORGANISM'S PRESENTATION.pptGENETICALLY MODIFIED ORGANISM'S PRESENTATION.ppt
GENETICALLY MODIFIED ORGANISM'S PRESENTATION.ppt
SyedArifMalki
 
Pteris : features, anatomy, morphology and lifecycle
Pteris : features, anatomy, morphology and lifecyclePteris : features, anatomy, morphology and lifecycle
Pteris : features, anatomy, morphology and lifecycle
Cherry
 
Major groups of bacteria: Spirochetes, Chlamydia, Rickettsia, nanobes, mycopl...
Major groups of bacteria: Spirochetes, Chlamydia, Rickettsia, nanobes, mycopl...Major groups of bacteria: Spirochetes, Chlamydia, Rickettsia, nanobes, mycopl...
Major groups of bacteria: Spirochetes, Chlamydia, Rickettsia, nanobes, mycopl...
Cherry
 

Recently uploaded (20)

Cot curve, melting temperature, unique and repetitive DNA
Cot curve, melting temperature, unique and repetitive DNACot curve, melting temperature, unique and repetitive DNA
Cot curve, melting temperature, unique and repetitive DNA
 
Lipids: types, structure and important functions.
Lipids: types, structure and important functions.Lipids: types, structure and important functions.
Lipids: types, structure and important functions.
 
Plasmid: types, structure and functions.
Plasmid: types, structure and functions.Plasmid: types, structure and functions.
Plasmid: types, structure and functions.
 
Taphonomy and Quality of the Fossil Record
Taphonomy and Quality of the  Fossil RecordTaphonomy and Quality of the  Fossil Record
Taphonomy and Quality of the Fossil Record
 
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
Chemistry Data Delivery from the US-EPA Center for Computational Toxicology a...
 
Molecular phylogeny, molecular clock hypothesis, molecular evolution, kimuras...
Molecular phylogeny, molecular clock hypothesis, molecular evolution, kimuras...Molecular phylogeny, molecular clock hypothesis, molecular evolution, kimuras...
Molecular phylogeny, molecular clock hypothesis, molecular evolution, kimuras...
 
Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.Porella : features, morphology, anatomy, reproduction etc.
Porella : features, morphology, anatomy, reproduction etc.
 
Genome organization in virus,bacteria and eukaryotes.pptx
Genome organization in virus,bacteria and eukaryotes.pptxGenome organization in virus,bacteria and eukaryotes.pptx
Genome organization in virus,bacteria and eukaryotes.pptx
 
SaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptx
SaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptxSaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptx
SaffronCrocusGenomicsThessalonikiOnlineMay2024TalkOnline.pptx
 
CYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptxCYTOGENETIC MAP................ ppt.pptx
CYTOGENETIC MAP................ ppt.pptx
 
GBSN - Biochemistry (Unit 3) Metabolism
GBSN - Biochemistry (Unit 3) MetabolismGBSN - Biochemistry (Unit 3) Metabolism
GBSN - Biochemistry (Unit 3) Metabolism
 
POGONATUM : morphology, anatomy, reproduction etc.
POGONATUM : morphology, anatomy, reproduction etc.POGONATUM : morphology, anatomy, reproduction etc.
POGONATUM : morphology, anatomy, reproduction etc.
 
ABHISHEK ANTIBIOTICS PPT MICROBIOLOGY // USES OF ANTIOBIOTICS TYPES OF ANTIB...
ABHISHEK ANTIBIOTICS PPT MICROBIOLOGY  // USES OF ANTIOBIOTICS TYPES OF ANTIB...ABHISHEK ANTIBIOTICS PPT MICROBIOLOGY  // USES OF ANTIOBIOTICS TYPES OF ANTIB...
ABHISHEK ANTIBIOTICS PPT MICROBIOLOGY // USES OF ANTIOBIOTICS TYPES OF ANTIB...
 
GENETICALLY MODIFIED ORGANISM'S PRESENTATION.ppt
GENETICALLY MODIFIED ORGANISM'S PRESENTATION.pptGENETICALLY MODIFIED ORGANISM'S PRESENTATION.ppt
GENETICALLY MODIFIED ORGANISM'S PRESENTATION.ppt
 
Pteris : features, anatomy, morphology and lifecycle
Pteris : features, anatomy, morphology and lifecyclePteris : features, anatomy, morphology and lifecycle
Pteris : features, anatomy, morphology and lifecycle
 
Major groups of bacteria: Spirochetes, Chlamydia, Rickettsia, nanobes, mycopl...
Major groups of bacteria: Spirochetes, Chlamydia, Rickettsia, nanobes, mycopl...Major groups of bacteria: Spirochetes, Chlamydia, Rickettsia, nanobes, mycopl...
Major groups of bacteria: Spirochetes, Chlamydia, Rickettsia, nanobes, mycopl...
 
FS P2 COMBO MSTA LAST PUSH past exam papers.
FS P2 COMBO MSTA LAST PUSH past exam papers.FS P2 COMBO MSTA LAST PUSH past exam papers.
FS P2 COMBO MSTA LAST PUSH past exam papers.
 
Sequence submission tools ............pptx
Sequence submission tools ............pptxSequence submission tools ............pptx
Sequence submission tools ............pptx
 
Precision Silviculture and Silviculture practices of bamboo.pptx
Precision Silviculture and Silviculture practices of bamboo.pptxPrecision Silviculture and Silviculture practices of bamboo.pptx
Precision Silviculture and Silviculture practices of bamboo.pptx
 
EU START PROJECT. START-Newsletter_Issue_4.pdf
EU START PROJECT. START-Newsletter_Issue_4.pdfEU START PROJECT. START-Newsletter_Issue_4.pdf
EU START PROJECT. START-Newsletter_Issue_4.pdf
 

FARMAKOKINETIKA DOSIS GANDA-III.ppt

  • 2. INFUSI - INTRAVENA INTRAVENA INTRAVENA BOLUS INTRAVENA LAMBAT – LAJU TETAP INFUSI INTRAVENA - PENGENDALIAN TEPAT Cp ~ kebutuhan pasien - HILANGKAN FLUKTUASI YANG BESAR CMAKS -- CMIN Ex. Oksitosin, heparin, aminofilin, cairan elektrolit, nutrient
  • 3. Fig. 5-1. Plasma level-time curve for constant IV infusion Pada keadaan tunak laju masukan obat = laju obat keluar (laju infusi) (laju eliminasi) dc/dt = 0
  • 4. OBAT – MODEL KOMPARTEMEN SATU B B kD R dt dD     kt D e k V R Cp    1   Cl R k V R e k V R Cp D D       1 Perubahan jumlah obat dalam tubuh pada berbagai waktu Integrasi persamaan di atas dan substitusi DB = CpVD Infusi berlanjut t = ~  e-kt mendekati nol DB = jumlah obat dalam tubuh R = laju infusi – order nol k = tetapan laju eliminasi – order satu CSS
  • 5. ?? LAJU INFUSI  CSS tSS Fig. 5-3. Plasma level – time curve for IV infusions given at rates of R and 2R, respectively
  • 6. CONTOH : Hal. 111 no.1 Suatu antibiotika Vd = 10 L, k = 0,2 jam-1, Css = 10 ug/mL Berapakah laju infusi untuk mempertahankan konsentrasi tersebut ?? R = Css Vd k R = (10 ug/m) (10.000 mL) ( 0,2 jam-1) R = 20 mg/jam Bila pasien dalam kondisi uremia, tetapan laju eliminasi menurun menjadi 0,1 jam-1 Laju infusi yang baru : R = (10 ug/m) (10.000 mL) ( 0,1 jam-1) R = 10 mg/jam
  • 7. INFUSI INTRAVENA  ClT, k, t1/2 Css R Cl Css R k Vd k Vd R C T SS                                   Css Cp Css t k kt Css Cp Css e Css Css Cp e Css Cp maka k V R Css karena e k V R Cp kt kt D kt D log 3 , 2 3 , 2 log 1 1 Lihat contoh hal 112 dan 113
  • 8. Fig 5-4. IV Infusion with loading dose DL DL is given by IV bolus injection at the start of infusion Cp decline exponentially after DL whereas they increase exponentially During the infusion. The resulting Cp versus time curve is a straight line due to the summation of the two curve DOSIS MUATAN PLUS INFUSI IV: MODEL KOMPARTEMEN SATU Apa tujuan DL???
  • 9. DOSIS MUATAN PLUS INFUSI IV: MODEL KOMPARTEMEN SATU 1 0 2 ( ) (1 ) kt kt L d L kt d DOSIS MUATAN D IV BOLUS INFUSI DENGAN LAJU R R C e C C e e V V D k         DL = Css Vd Css . Vd= R/k DL = R/k !! Css  C terapetik Css 1 2 (1 ) ( ) ( ) L kt d kt d d kt L kt L d kt L d kt L d L d d L d d D e V D e D dan AWAL INFUSI WAKTU SAMA Cp C C R Cp e V k R R Cp e V k V k D D Cp e V D e V V D R Cp V V k V                     Css
  • 10. Fig. 5-5. IV Infusion with loading doses a, b, and c. Curve d represents an IV infusion without a loading dose a  DL > R/k b  DL = R/k c  DL < R/k !! Cara lain perhit DL DL = Css . Vd
  • 11. Cp – SETELAH INFUSI DIHENTIKAN t – waktu infusi + post infusi b – waktu infusi   ) ( 1 . b t k kb e e k Vd R Cp      CARA LAIN LIHAT HAL 191 LIHAT LATIHAN SOAL HAL. 118 dst. INFUSI IV INTERMITTEN HAL 197 PRINSIP SAMA
  • 12. REGIMENTASI DOSIS ORAL GANDA N – jumlah dosis - jarak pendosisan F – fraksi dosis terabsorpsi t – waktu setelah do ke n                                    kt k nk t k k nk e e e e e e ka k Vd D ka F Cp a a a     1 1 1 1 ) ( . . 0      T av av D av Cl FD C AUC C k V FD C 0 ~ ~ 0 ~ 0 ~   